流行SARS-CoV-2變異株產(chǎn)品大合集
日期:2021-08-25 16:14:47
2019年底爆發(fā)的COVID19疫情仍在全球肆虐。SARS-CoV-2,作為這種流行病的起因,突變速度令人瞠目結(jié)舌。SARS-CoV-2僅用了一年多的時間,從 Alpha 發(fā)展到 Lambda,讓W(xué)HO用了將近 1/2 的希臘字母來為其變異株命名。2020年12月末,在英國發(fā)現(xiàn)SARS-CoV-2變異株Alpha,至此,英國疫情失控。緊接著,在南非發(fā)現(xiàn)了變異株Beta,在印度發(fā)現(xiàn)了變異株Delta,在秘魯發(fā)現(xiàn)了變異株Lambda。
針對全球SARS-CoV-2的主要變種,華美生物可提供多種標(biāo)簽的優(yōu)質(zhì)突變抗原。絕大多數(shù)突變抗原已驗證生物活性。
如果您對其他突變株感興趣,可點擊頁面右側(cè)的在線咨詢聯(lián)系我們定制。➤➤➤
>>SARS-CoV-2 Lambda | C.37 (南美突變株)
Target | Product Name | Code | Source | Mutation | Tag Info |
---|---|---|---|---|---|
N | Recombinant Human Novel Coronavirus Nucleoprotein (N) (R203K,G204R) (Active) | CSB-EP3325GMY(M12) | E.coli | R203K, G204R | N-terminal 6xHis-tagged |
>>SARS-CoV-2 Delta | B.1.617.2 (印度突變株)
Target | Product Name | Code | Source | Mutation | Tag Info |
---|---|---|---|---|---|
N | Recombinant Human Novel Coronavirus Nucleoprotein (N) (D63G,R203M,D377Y) (Active) | CSB-EP3325GMY(M14) | E.coli | D63G, R203M, D377Y | N-terminal 6xHis-tagged |
>>SARS-CoV-2 Kappa | B.1.617.1 (印度突變株)
Target | Product Name | Code | Source | Mutation | Tag Info |
---|---|---|---|---|---|
N | Recombinant Human Novel Coronavirus Nucleoprotein (N) (R203M,D377Y) (Active) | CSB-EP3325GMY(M13) | E.coli | R203M, D377Y | N-terminal 6xHis-tagged |
>>SARS-CoV-2 Alpha | B.1.1.7 (英國突變株)
Target | Product Name | Code | Source | Mutation | Tag Info |
---|---|---|---|---|---|
N | Recombinant Human Novel Coronavirus Nucleoprotein (N) (D3L,R203K,G204R,S235F) (Active) | CSB-EP3325GMY(M1) | E.coli | D3L, R203K, G204R, S235F | N-terminal 6xHis-tagged |
N | Recombinant Human Novel Coronavirus Nucleoprotein (N) (R203K,G204R) (Active) | CSB-EP3325GMY(M12) | E.coli | R203K, G204R | N-terminal 6xHis-tagged |
S1 | Recombinant Human Novel Coronavirus Spike glycoprotein (S) (D614G),partial (Active) | CSB-MP3324GMY(M1) | Mammalian cell | D614G | C-terminal 10xHis-tagged |
S1-RBD | Recombinant Human Novel Coronavirus Spike glycoprotein (S) (N501Y),partial (Active) | CSB-MP3324GMY1(M6) | Mammalian cell | N501Y | C-terminal 10xHis-tagged |
S1-RBD | Recombinant Human Novel Coronavirus Spike glycoprotein (S) (N501Y),partial (Active) | CSB-MP3324GMY1(M6)k2 | Mammalian cell | N501Y | C-terminal 6xHis-mFC-tagged |
>>SARS-CoV-2 Beta | B.1.351 (南非突變株)
>>SARS-CoV-2 Gamma | P.1 (巴西突變株)
Target | Product Name | Code | Source | Mutation | Tag Info |
---|---|---|---|---|---|
N | Recombinant Human Novel Coronavirus Nucleoprotein (N) (P80R) (Active) | CSB-EP3325GMY(M3) | E.coli | P80R | N-terminal 6xHis-tagged |
S1 | Recombinant Human Novel Coronavirus Spike glycoprotein (S) (D614G),partial (Active) | CSB-MP3324GMY(M1) | Mammalian cell | D614G | C-terminal 10xHis-tagged |
S1-RBD | Recombinant Human Novel Coronavirus Spike glycoprotein (S) (N501Y),partial (Active) | CSB-MP3324GMY1(M6) | Mammalian cell | N501Y | C-terminal 10xHis-tagged |
S1-RBD | Recombinant Human Novel Coronavirus Spike glycoprotein (S) (N501Y),partial (Active) | CSB-MP3324GMY1(M6)k2 | Mammalian cell | N501Y | C-terminal 6xHis-mFC-tagged |
S1-RBD | Recombinant Human Novel Coronavirus Spike glycoprotein(S)(E484K),partial | CSB-MP3324GMY1(M8) | Mammalian cell | E484K | C-terminal 10xHis-tagged |
S1-RBD | Recombinant Human Novel Coronavirus Spike glycoprotein(S) (E484K), partial (Active) | CSB-MP3324GMY1(M8)h8 | Mammalian cell | E484K | C-terminal mFC-tagged |
>>其他SARS-CoV-2 突變株
>>部分驗證數(shù)據(jù)
● Recombinant Human Novel Coronavirus Nucleoprotein (N)(R203K,G204R) (Active) (CSB-EP3325GMY(M12))